Standard Medical & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 03-12-2024
- Paid Up Capital ₹ 10.85 Cr
as on 03-12-2024
- Company Age 41 Year, 2 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 37.16 Cr
as on 03-12-2024
- Revenue -60.87%
(FY 2018)
- Profit -365.86%
(FY 2018)
- Ebitda 46.14%
(FY 2018)
- Net Worth -0.03%
(FY 2018)
- Total Assets %
(FY 2018)
About Standard Medical & Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 10.85 Cr.
The company currently has active open charges totaling ₹37.16 Cr.
Prasad Kanumuri, Rajagopal Vemareddy, Subhash Devalla, and One other member serve as directors at the Company.
- CIN/LLPIN
L24239TG1983PLC004152
- Company No.
004152
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Sep 1983
- Date of AGM
28 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Standard Medical & Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasad Kanumuri  | Managing Director | 28-Sep-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajagopal Vemareddy | Director | 29-Nov-2000 | Current |
| Subhash Devalla | Director | 28-Sep-2018 | Current |
| Sailaja Aluru | Director | 24-Mar-2015 | Current |
Financial Performance of Standard Medical & Pharmaceuticals.
Standard Medical & Pharmaceuticals Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 60.87% decrease. The company also saw a substantial fall in profitability, with a 365.86% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Standard Medical & Pharmaceuticals?
In 2018, Standard Medical & Pharmaceuticals had a promoter holding of 5.87% and a public holding of 94.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adala Farms Private LimitedActive 18 years 8 monthsSubhash Devalla and Sailaja Aluru are mutual person
- Bluegum Plantations (Andhra Pradesh) Private LimitedActive 18 years 5 months
Sailaja Aluru is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Hyderabad Creation Date: 03 Apr 1996 | ₹1.00 M | Open |
The Peerless General Finance & Investment Co. Ltd Creation Date: 07 Oct 1994 | ₹2.00 Cr | Open |
State Bank Of Hyderabad Creation Date: 20 Jun 1990 | ₹2.50 M | Open |
How Many Employees Work at Standard Medical & Pharmaceuticals?
Unlock and access historical data on people associated with Standard Medical & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Standard Medical & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Standard Medical & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
